Patents by Inventor May Kung Sutherland

May Kung Sutherland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-MSLN BINDING AGENTS, CONJUGATES THEREOF AND METHODS OF USING THE SAME
    Publication number: 20240024502
    Abstract: The present disclosure provides anti-MSLN antibodies, antigen binding portions thereof and MSLN conjugates thereof for use in the treatment of cancer.
    Type: Application
    Filed: October 15, 2021
    Publication date: January 25, 2024
    Inventors: May Kung SUTHERLAND, Maria Leia SMITH
  • GPC3 BINDING AGENTS, CONJUGATES THEREOF AND METHODS OF USING THE SAME
    Publication number: 20240024499
    Abstract: The present invention provides anti-GPC3 antibodies, antigen binding portions thereof and GPC3 conjugates thereof for use in the treatment of cancer.
    Type: Application
    Filed: November 19, 2021
    Publication date: January 25, 2024
    Inventors: Maria Leia SMITH, May Kung SUTHERLAND
  • CD123 Antibodies and Conjugates Thereof
    Publication number: 20210128742
    Abstract: The invention provides murine, chimeric, and humanized antibodies that specifically bind to CD123 and conjugates thereof.
    Type: Application
    Filed: January 5, 2021
    Publication date: May 6, 2021
    Applicant: Seagen Inc.
    Inventors: May Kung Sutherland, Lori Westendorf, Django Sussman
  • CD33 ANTIBODIES AND USE OF SAME TO TREAT CANCER
    Publication number: 20210047404
    Abstract: The invention provides murine, chimeric, and humanized antibodies that specifically hind to CD33. The antibodies are useful for treatment and diagnoses of various cancers as well as detecting CD33.
    Type: Application
    Filed: July 29, 2020
    Publication date: February 18, 2021
    Applicant: SEATTLE GENETICS, INC.
    Inventors: May Kung Sutherland, Maureen Ryan, Django Sussman, Patrick Burke, Scott Jeffrey
  • CD123 antibodies and conjugates thereof
    Patent number: 10912842
    Abstract: The invention provides murine, chimeric, and humanized antibodies that specifically bind to CD123 and conjugates thereof.
    Type: Grant
    Filed: June 9, 2016
    Date of Patent: February 9, 2021
    Assignee: Seattle Genetics, Inc.
    Inventors: May Kung Sutherland, Lori Westendorf, Django Sussman
  • CD33 antibodies and use of same to treat cancer
    Patent number: 10787514
    Abstract: The invention provides murine, chimeric, and humanized antibodies that specifically hind to CD33. The antibodies are useful for treatment and diagnoses of various cancers as well as detecting CD33.
    Type: Grant
    Filed: January 20, 2017
    Date of Patent: September 29, 2020
    Assignee: SEATTLE GENETICS, INC.
    Inventors: May Kung Sutherland, Maureen Ryan, Django Sussman, Patrick Burke, Scott Jeffrey
  • CD123 ANTIBODIES AND CONJUGATES THEREOF
    Publication number: 20180169261
    Abstract: The invention provides murine, chimeric, and humanized antibodies that specifically bind to CD123 and conjugates thereof.
    Type: Application
    Filed: June 9, 2016
    Publication date: June 21, 2018
    Applicant: SEATTLE GENETICS, INC.
    Inventors: May Kung Sutherland, Lori Westendorf, Django Sussman
  • CD33 ANTIBODIES AND USE OF SAME TO TREAT CANCER
    Publication number: 20170204180
    Abstract: The invention provides murine, chimeric, and humanized antibodies that specifically hind to CD33. The antibodies are useful for treatment and diagnoses of various cancers as well as detecting CD33.
    Type: Application
    Filed: January 20, 2017
    Publication date: July 20, 2017
    Inventors: May Kung Sutherland, Maureen Ryan, Django Sussman, Patrick Burke, Scott Jeffrey
  • CD33 antibodies and use of same to treat cancer
    Patent number: 9587019
    Abstract: The invention provides murine, chimeric, and humanized antibodies that specifically bind to CD33. The antibodies are useful for treatment and diagnoses of various cancers as well as detecting CD33.
    Type: Grant
    Filed: May 15, 2013
    Date of Patent: March 7, 2017
    Assignee: SEATTLE GENETICS, INC.
    Inventors: May Kung Sutherland, Maureen Ryan, Django Sussman, Patrick Burke, Scott Jeffrey
  • CD33 ANTIBODIES AND USE OF SAME TO TREAT CANCER
    Publication number: 20150147316
    Abstract: The invention provides murine, chimeric, and humanized antibodies that specifically bind to CD33. The antibodies are useful for treatment and diagnoses of various cancers as well as detecting CD33.
    Type: Application
    Filed: May 15, 2013
    Publication date: May 28, 2015
    Applicant: SEATTLE GENETICS, INC.
    Inventors: May Kung Sutherland, Maureen Ryan, Django Sussman, Patrick Burke, Scott Jeffrey
  • CD33 Antibodies And Use Of Same To Treat Cancer
    Publication number: 20130309223
    Abstract: The invention provides murine, chimeric, and humanized antibodies that specifically bind to CD33. The antibodies are useful for treatment and diagnoses of various cancers as well as detecting CD33.
    Type: Application
    Filed: March 14, 2013
    Publication date: November 21, 2013
    Inventors: MAY KUNG SUTHERLAND, MAUREEN RYAN, DJANGO SUSSMAN, PATRICK BURKE, SCOTT JEFFREY
  • METHODS OF TREATING NEOPLASTIC, AUTOIMMUNE AND INFLAMMATORY DISEASES
    Publication number: 20110038856
    Abstract: Methods of treating cancer and autoimmune and inflammatory diseases are provided.
    Type: Application
    Filed: November 2, 2007
    Publication date: February 17, 2011
    Applicant: Seattle Genetics, Inc.
    Inventors: Jonathan G. Drachman, May Kung Sutherland, Eric Sievers, Grant Risdon, Ezogelin Gruyters, Alan Wahl, Tim Lewis
  • METHODS OF TREATING NEOPLASTIC, AUTOIMMUNE AND INFLAMMATORY DISEASES
    Publication number: 20100215653
    Abstract: Methods of treating cancer and autoimmune and inflammatory diseases are provided.
    Type: Application
    Filed: February 26, 2010
    Publication date: August 26, 2010
    Applicant: Seattle Genetics, Inc.
    Inventors: Jonathan G. Drachman, May Kung Sutherland, Eric Sievers, Grant Risdon, Ezogelin Oflazoglu, Alan Wahl, Tim Lewis
  • Methods of treating neoplastic, autoimmune and inflammatory diseases
    Patent number: 7695716
    Abstract: Methods of treating cancer and autoimmune and inflammatory diseases are provided.
    Type: Grant
    Filed: April 11, 2008
    Date of Patent: April 13, 2010
    Assignee: Seattle Genetics, Inc.
    Inventors: Jonathan G. Drachman, May Kung Sutherland, Eric Sievers, Grant Risdon, Alan Wahl, Tim Lewis
  • METHODS OF TREATING NEOPLASTIC, AUTOIMMUNE AND INFLAMMATORY DISEASES
    Publication number: 20080267960
    Abstract: Methods of treating cancer and autoimmune and inflammatory diseases are provided.
    Type: Application
    Filed: April 11, 2008
    Publication date: October 30, 2008
    Applicant: Seattle Genetics, Inc.
    Inventors: Jonathan G. Drachman, May Kung Sutherland, Eric Sievers, Grant Risdon, Ezogelin Oflazoglu, Alan Wahl, Tim Lewis